Stratos Wealth Partners’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-14,100	Closed	-$65.6K	–	1434
2024 Q1	$65.6K	Sell	14,100 -2,400	-15%	-$11.2K	﹤0.01%	1352
2023 Q4	$68.3K	Buy	16,500 +500	+3%	+$2.07K	﹤0.01%	1334
2023 Q3	$48K	Buy	+16,000	New	+$48K	﹤0.01%	1255